Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128654) titled 'Discovery and Mechanistic Investigation of Anhedonia-Based Biomarkers for Depression Diagnosis and Treatment' on July 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University Sixth Hospital ( Institute of Mental Health )
Condition:
major depressive disorder
anhedonia
Intervention:
Stable Medication Treatment + tTIS Group:Original therapeutic drug+Transcranial temporal interference stimulation
Stable Medication Treatment + Placebo Capsule Group:Original therapeutic drug+Placebo Capsule
Stable Medication Treatment + Omega-3 PUFAs Group:Original therapeutic drug+Omega-3 PU...